Asia-Pacific region symposium – One Dose HPV Vaccine Update: where are we now?

Date Posted – 20 July 2021
Event Date – 23 July 2021

Presented by the Single-dose HPV Vaccine Evaluation Consortium in conjunction with VCS Foundation and the National Centre for Immunisation Research and Surveillance (Australia).

The Single-dose HPV Vaccine Evaluation Consortium recently released evidence on the potential for single-dose HPV vaccination to inform global policy discussions and program guidance, as well as to raise awareness and understanding of its implications. If demonstrated to be effective, single-dose HPV vaccination could facilitate new options for current national programs by simplifying delivery and lowering program costs, potentially accelerating introduction of HPV vaccines into national immunisation schedules.

This symposium will feature a presentation from, and a facilitated Q and A session with, members of the Consortium on existing and forthcoming evidence on the efficacy, immunogenicity, effectiveness, and cost effectiveness of single dose HPV vaccination from:

  • clinical trials
  • observational studies
  • modelling analyses


  • Friday 23 July
  • 5.00-6.30pm AEST
  • Virtual Event


  • Prof Deborah-Watson Jones, Clinical Epidemiology & International Health in the Clinical Research Department, The London School of Hygiene & Tropical Medicine (LSHTM)
  • Hilary Whitworth, Clinical Research Department, LSHTM
  • Prof Mark Jit, Centre for the Mathematical Modelling of Infectious Diseases, LSHTM
  • Dr Kiesha Prem, Research Fellow, Centre for the Mathematical Modelling of Infectious Diseases, LSHTM

Register here


News & opinion

Member Directory